Clinical Trial Update: Use of N-Acetylcysteine During Liver Procurement [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports the completion of a Phase 2 study evaluating the use of N-acetylcysteine during liver procurement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Disease
• Liver Failure
• Liver Neoplasms

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Azienda Ospedaliera di Padova | Conditions: Liver Failure, Liver Failure, Acute | Phase 2 | Status: COMPLETED